Monthly letter · News · Topics · Identity · Dispatches · Est. 2026

Where the Real You Learns to Live, not Just Stand Up

TheSignal

Women

Menopause and depression: a Lancet review reported by Brigham and Women's found no evidence it universally raises the risk

Harvard Gazette, byline BWH Communications · Mar 11, 2024 (page modified Feb 4, 2025) · review of earlier studies in The Lancet, no sample reported

James H. Tippins

The review separates a stage of life from a diagnosis. According to the page, severe depression during the transition appeared only in people with an earlier diagnosis, while depressive symptoms were more common among those with prior depression, sleep broken by hot flushes at night, or a stressful event at the same time. The authors raise the concern that blaming distress on menopause could delay accurate diagnosis. The evidence comes mostly from high-income countries, and it is thinner for anxiety, bipolar disorder and psychosis.

Why it matters to this work. The review sorts out who reported depressive symptoms around menopause and what else was happening in their lives. It reads earlier studies and does not follow new participants. Invisible Contracts

When you feel off during a season of change, which explanations do you reach for first, and which do you skip?

Where Are You Standing? → Six questions, two minutes, no email.

The story

Illustration

The Harvard Gazette page, from Brigham and Women's Hospital communications, describes a review in The Lancet of earlier studies on depressive symptoms, major depression, anxiety, bipolar disorder and psychosis during menopause. It reports no evidence that menopause universally raises the risk of these conditions. Some studies linked menopause to depressive symptoms, but more severe clinical depression during the transition occurred only in people previously diagnosed with depression. The groups named as higher risk for depressive symptoms included people with a previous history of depression, people whose sleep was severely disrupted by hot flushes at night, people who had a stressful life event alongside menopause, and people with a very long transition. Evidence for anxiety, bipolar disorder and psychosis was described as weaker because the literature is scarcer.

The page gives the transition as lasting four to 10 years and beginning at about age 47 on average. The review gave greater weight to prospective studies that assessed mental health before menopause as well as during or after it. The page states that most menopause studies come from high-income countries, that little is known about menopause in transgender and gender-diverse people, and that the evidence on anxiety, bipolar disorder and psychosis is thinner than on depression. It reports no sample size, since this is a review. The authors say that misattributing distress to menopause could delay accurate diagnosis and could create negative expectations for women approaching middle age.

Read at Harvard Gazette, Menopause depression risk has been exaggerated →

More from James